Medincell SA (MEDCL)

Paris
Currency in EUR
15.80
-0.40(-2.47%)
Closed·
MEDCL Scorecard
Full Analysis
High shareholder yield
MEDCL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.3916.15
52 wk Range
12.0019.00
Key Statistics
Edit
Prev. Close
15.8
Open
16.1
Day's Range
15.39-16.15
52 wk Range
12-19
Volume
133.8K
Average Volume (3m)
74.89K
1-Year Change
6.33%
Book Value / Share
-1.63
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDCL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
22.77
Upside
+44.12%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Medincell SA News & Analysis

Show more

Medincell Company Profile

MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology; and offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults. The company’s products in development include mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation; and mdc-TJK, a subcutaneous injection that is in Phase III clinical trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. MedinCell S.A. was incorporated in 2003 and is headquartered in Jacou, France.

Employees
131
Market
France

Compare MEDCL to Peers and Sector

Metrics to compare
MEDCL
Peers
Sector
Relationship
P/E Ratio
−28.3x15.0x−0.5x
PEG Ratio
-−0.020.00
Price/Book
−9.7x1.5x2.6x
Price / LTM Sales
18.8x2.9x3.1x
Upside (Analyst Target)
39.2%77.6%47.8%
Fair Value Upside
Unlock17.5%6.9%Unlock

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 22.77
(+44.12% Upside)

Earnings

Latest Release
Jun 17, 2025
EPS / Forecast
-0.17 / -0.17
Revenue / Forecast
4.90M / 5.70M
EPS Revisions
Last 90 days

MEDCL Income Statement

FAQ

What Is the Medincell (MEDCL) Stock Price Today?

The Medincell stock price today is 15.80.

What Stock Exchange Does Medincell Trade On?

Medincell is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Medincell?

The stock symbol for Medincell is "MEDCL."

What Is the Medincell Market Cap?

As of today, Medincell market cap is 522.49M.

What Is Medincell's Earnings Per Share (TTM)?

The Medincell EPS (TTM) is 0.00.

When Is the Next Medincell Earnings Date?

Medincell will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is MEDCL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Medincell Stock Split?

Medincell has split 0 times.

How Many Employees Does Medincell Have?

Medincell has 131 employees.

What is the current trading status of Medincell (MEDCL)?

As of 09 Jul 2025, Medincell (MEDCL) is trading at a price of 15.80, with a previous close of 15.80. The stock has fluctuated within a day range of 15.39 to 16.15, while its 52-week range spans from 12.00 to 19.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.